版本:
中国

BRIEF-Navidea Biopharmaceuticals enters asset purchase agreement with Cardinal Health

Nov 23 Navidea Biopharmaceuticals Inc :

* Press release - Navidea signs asset purchase agreement with Cardinal Health

* Navidea will receive $80 million at closing, plus opportunity to earn up to $230 million of contingent consideration

* Says as part of transaction, Cardinal Health will license a portion of acquired intellectual property back to Navidea

* Could earn contingent consideration based on certain milestones through 2026, with $20.1 million of that amount guaranteed over next 3 years Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐